How effective is Plaquenil for Lupus Encephalitis? (a real world drug study)

Summary:

Overall ratings: 3/5
Long term ratings: 3.4/5

This is a phase IV clinical study of how effective Plaquenil (hydroxychloroquine sulfate) is for Lupus encephalitis and for what kind of people. The study is created by eHealthMe from 9 Plaquenil users and is updated continuously.

What is Plaquenil?

Plaquenil has active ingredients of hydroxychloroquine sulfate. It is often used in systemic lupus erythematosus. eHealthMe is studying from 91,018 Plaquenil users. Check the latest studies of Plaquenil.

What is Lupus encephalitis?

Lupus encephalitis (a chronic inflammatory autoimmune disorder that may affect brain) is found to be associated with 16 drugs and 34 conditions by eHealthMe. Check the latest studies of Lupus encephalitis.


On Aug, 08, 2026

9 people are studied for taking Plaquenil in Lupus encephalitis

Overall effectiveness (number of people):

Does Plaquenil work for your Lupus encephalitis (overall)?

Long term (1+ years) effectiveness (number of people):

Does Plaquenil work for your Lupus encephalitis (long term)?

Plaquenil effectiveness for Lupus encephalitis (number of people):

Overall:
  • not at all: 0
  • somewhat: 2
  • moderate: 5
  • high: 2
  • very high: 0
Long Term:
  • not at all: 0
  • somewhat: 0
  • moderate: 3
  • high: 2
  • very high: 0

Gender of people who take Plaquenil for Lupus encephalitis *:

  • female: 100 %
  • male: 0.0 %

Age of people who take Plaquenil for Lupus encephalitis *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 11.11 %
  • 30-39: 11.11 %
  • 40-49: 22.22 %
  • 50-59: 44.44 %
  • 60+: 11.11 %

Who find Plaquenil more effective for Lupus Encephalitis?

Gender of people who take Plaquenil for Lupus encephalitis *:

  • female: 100 %
  • male: 0.0 %

Age of people who take Plaquenil for Lupus encephalitis *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 100 %
  • 60+: 0.0 %

* Approximation only. Some reports may have incomplete information.

Do you take Plaquenil?

- You can start a phase IV clinical trial to monitor Plaquenil safety and effectiveness.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Related studies

Alternative drugs to, pros and cons of:

Treatments, associated drugs and conditions:

How the study uses the data?

The study is based on hydroxychloroquine sulfate (the active ingredients of Plaquenil) and Plaquenil (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study neither.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: